All In MedTech

Device Trial Radar · NCT04198441

The Omeza Protocol for Chronic Ulcers

A Randomized, Multicenter, Open Label Study Comparing the Omeza® Products Bundle to Standard of Care for Chronic Venous Leg Ulcers and Chronic Diabetic Foot Ulcers

Last checked: Nov 20, 2026Latest source record: Apr 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

78

Planned (sponsor's estimate)

Start

Jun 2, 2020

Primary completion

Oct 2021

Study completion Dec 2021

Sponsor

Lead sponsor
Omeza, LLCNot on our public-company list
Sponsor type
Industry
First posted
Dec 13, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will compare the Omeza® Products Bundle to standard of care (SOC) for in subjects with chronic venous leg ulcers and subjects with diabetic foot ulcers.

Conditions

  • Venous Leg Ulcer
  • Diabetic Foot Ulcer

Interventions

  • Wound dressingDevice

    Clean wound, fill wound, dress wound

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Wound ClosureTime frame: 13 weeks
  2. Wound Closure RateTime frame: 13 weeks
  3. Time to Maximum Wound ClosureTime frame: 1-13 weeks

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • First Coast Cardiovascular Institute

    Jacksonville, Florida · Recruiting

  • Saint Michael's Medical Center

    Newark, New Jersey · Recruiting

  • Oregon Health & Science University (OHSU)

    Portland, Oregon · Recruiting

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.